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Background: The prevalence of severe obesity in children and adolescents is increasing. However, little is known
about cardiometabolic risk factors and quality of life of children with severe obesity.
Therefore, the aim of this study was to assess the demographic characteristics and the prevalence of
cardiometabolic risk factors and quality of life in severely obese children and adolescents undergoing intensive
inpatient treatment for obesity.
Methods: Data were collected between August 2009 and April 2011 on 16 children (8-13y) and 64 adolescents
(13-19y) with severe obesity (SDS-BMI >= 3.0 or SDS-BMI >= 2.3 and comorbidity) participating in an RCT evaluating
two intensive inpatient treatment programs for obesity. Demographic, anthropometric, clinical characteristics and
two components of the EuroQol for the assessment of quality of life are described.
Results: Eighty percent of participants in this study had at least one cardiometabolic risk factor in addition to
severe obesity. Low HDL-cholesterol and hypertension were most prevalent (65.0% respectively 31.2%). The highest
significant correlations were found between SDS-BMI and SDS-waist circumference, fasting plasma insulin and
HOMA-IR (correlation coefficients respectively 0.80, 0.49, and 0.48). With regard to quality of life, the mean utility
score of the participants was 0.79 on a scale of 0.0 to 1.0 on the EuroQol questionnaire and their mean individual
valuation was 69.1 on a scale of 0 to100.
Conclusion: Cardiometabolic risk factors are already highly prevalent in this group of severely obese children and
adolescents. The score of 69.1 found for quality of life in this study suggests that participants experience important
limitations in their quality of life. However, quality of life is not associated with the prevalence of cardiometabolic
risk factors.
Trial registration: Netherlands Trial Register (NTR1678, registered 20-Feb-2009)
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Worldwide there has been a large increase in the preva-
lence of obesity in children and adolescents in the last
decades [1,2]. In 2009 in the Netherlands, about 2% of
the boys and girls were classified as obese. In compari-
son with 1980 these figures indicate a four to six fold
higher prevalence for obesity [3]. Moreover, the severity* Correspondence: s.makkes@vu.nl
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reproduction in any medium, provided the orof obesity has also increased, both in the Netherlands as in
other countries. Results from the 2009–2010 NHANES in-
dicate that an estimated 16.9% of children and adolescents
aged 2–19 years in the US are obese [4]. The rate of severe
childhood obesity has tripled in the last 25 years [5]. This
trend is worrisome, because obese children have a higher
risk of type 2 diabetes mellitus and cardiometabolic risk
factors such as high blood pressure, low HDL cholesterol,
high triglycerides and high fasting insulin concentration
[6-9]. These cardiometabolic risk factors are often clus-
tered together in individuals which increases the risk of
cardiometabolic disease in young adulthood [10]. InLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and is related to cardiometabolic disease, diabetes type 2
and even cancer in later life, independent of adult BMI
[11-13]. Besides these negative clinical consequences of
obesity, low self esteem and behavioral problems seem to
be particularly common in obese children [10]. Obese
children and adolescents also have psychological problems
and a lower health-related quality of life [14]. Although it
can be expected that the health consequences of severe
obesity are even more serious than of obesity, little is
known about the demographic, anthropometric and clin-
ical characteristics of severely obese children and adoles-
cents. This information is important as it will give more
insight into the health risks of these children. Therefore,
the objective of this article is to assess the prevalence of
cardiometabolic risk factors and the quality of life in se-
verely obese children and adolescents undergoing inten-
sive inpatient treatment for obesity in the Netherlands.Methods
Design
Data were collected between August 2009 and April
2011 on 16 children (8-13y) and 64 adolescents (13-19y)
with severe obesity who participated in the Health Ef-
fects of Lifestyle Interventions in severely Obese chil-
dren and adolescents Study (HELIOS). HELIOS is a
randomized controlled trial (RCT) in which the cost-
effectiveness of two treatment programs aimed at chan-
ging the lifestyle of both participants and their parents is
compared. These children receive one year of intensive
treatment starting with either an inpatient period of two
or six months in a tertiary obesity center in Hilversum,
the Netherlands. After the intensive treatment period,
there is follow-up of one year. Details about the design
of the study and the two treatment programs can be
found elsewhere [15].Participants
Inclusion criteria for the trial were a SDS-BMI >= 3.0
(this corresponds to the 99.9th percentile) according to
the growth curves based on the fourth Dutch nationwide
growth study of 1997, or a SDS-BMI >= 2.3 (this corre-
sponds to the 99th percentile) and comorbidity (e.g. ob-
structive sleep apnea syndrome, raised insulin, diabetes
type II, liver function disorders, dyslipidemia, worn out
joints). Participants were excluded from the trial if they
had syndromal or chromosomal determined obesity;
obesity caused by endocrine disorders (hypothyroidism,
Cushing syndrome, primary hyperinsulinemia, pseudo-
hypoparathyroidism, acquired (structural) hypothalamic
damage) or medicine use (e.g. oral steroids, antiepileptic
drugs, antidepressants); psychiatric problems; an IQ
below 75 or similar school level or if their parents werenot willing or able to participate in the treatment pro-
gram and/or study.
Measurements
Data on demographic characteristics, comorbidities and
quality of life were obtained by questionnaires com-
pleted by the participants and their parents. Participants
were categorized into two main groups for ethnicity; Na-
tive Dutch and Immigrant (Western and Non-Western).
When both parents were born abroad in different coun-
tries, the country in which the mother was born was
used to classify the participant [16]. Highest educational
level attained by one of the parents was used for analysis
and is divided into low (lower vocational training, lower
general secondary education and primary school and
special primary education or less), medium (intermediate
vocational training, higher general secondary training
and pre-university education) or high (completed higher
vocational training and university) [17,18]. To determine
socio economic status (SES) of the participants, we used
status scores of the parents using data from The
Netherlands Institute for Social Research [19]. A status
score is a measure for the social status of a postal code
area and consists of three elements: income, level of
education and level of unemployment. A status score
below 0 means a SES above average and a status score
above 0 means a SES below average (0 meaning average)
[19]. Quality of life was measured using the EuroQol
(EQ-5D-3 L) [20]. The EuroQol consists of two compo-
nents; the EQ-5D descriptive system and the EQ visual
analogue scale (EQ VAS). Both the EQ-5D and EQ-VAS
were completed by the participants. The EQ-5D descrip-
tive system consists of five dimensions (mobility, self care,
usual activities, pain/discomfort, and anxiety/depression)
with three levels of severity (no problems/some or moder-
ate problems/extreme problems). The participants were
asked to choose the level that best described their current
health status for each dimension. The resulting health
state was converted to a utility score using the Dutch EQ-
5D valuation tariff [21]. Utilities represent quality of life in
a single number along a continuum ranging from 0.0
(death) to 1.0 (full health). In the EQ-VAS a standard
vertical 20 cm visual analogue scale is used to measure
an individual’s direct valuation of their current health-
related quality of life on a scale of 0 (worst imaginable
health state) to 100 (best imaginable health state) [20].
Comorbidity (acanthosis nigricans, Blount’s disease,
gallstones, hirsutism and pseudogynecomastia) was de-
termined by the treating pediatricians from obesity cen-
ter Heideheuvel before start of the treatment and by
ultrasound. A clear description of the anthropometric
measurements that were performed can be found else-
where [15]. The equation used for the children and ado-
lescents in this study to calculate fat mass percentage
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adjusted by Newton et al. [22,23]. After an overnight
fast, blood samples were obtained to measure lipid
spectrum, high sensitive C-reactive protein (HS-CRP)
and hemoglobin type A1C (HbA1C). To determine glu-
cose tolerance and insulin resistance, the participants
were given glucose, in a dose of 1.75 g per kilogram of
body weight (up to a maximum of 75 g) orally. Blood
samples were obtained at 0 and 120 minutes for the
measurement of glucose and insulin levels. Homeostasis
model assessment for insulin resistance (HOMA-IR)
was calculated using the following equation: fasting
plasma insulin (μU/L) x fasting glucose (mmol/L)/22.5.
Scores ordinarily range from 0 to 15, with higher scores
indicating greater insulin resistance. Insulin resistance
was determined using the cut-off points of Kurtoğlu
et al. for participants in the prepubertal and pubertal
stage (prepubertal: 2.67 in boys and 2.22 in girls, puber-
tal: 5.22 in boys and 3.82 in girls) [24,25]. For partici-
pants in the postpubertal stage, the adult cut-off point
of > 2.5 from Keskin et al. was used [26]. The three pu-
bertal stages, prepubertal, pubertal and postpubertal,
were based on Tanner stages: prepubertal equals G/
M1&P1; postpubertal equals G/M5&P5; pubertal equals
all other Tanner stages. For all participants the presence
of a number of well known cardiometabolic risk factors
was determined [27,28]. The definitions of these car-
diometabolic risk factors are included in the Additional
file 1.
Statistical analyses
All analyses were performed with IBM SPSS Statistics for
Windows, Version 20. Results were stratified by age,
where participants in the age group 8 to 13 years were cat-
egorized as ‘children’ and participants in the age group 13
to 19 years were categorized as ‘adolescents’. Results were
also stratified according to SDS-BMI median (SDS-BMI =
3.49). Independent Student’s t-tests were used to analyze
differences in continuous measures between the age
groups. Chi-square tests were used to analyze differences
in categorical variables. Because several variables had dis-
tributions that deviated from normality, Spearman’s rank
correlations were calculated. Spearman’s rank correlations
were used to explore the relationship between SDS-BMI
and anthropometric and laboratory measurements, such
as blood pressure, blood lipids, insulin and glucose. In
addition to SDS-BMI, also the relationship between utility
score and these outcomes was explored. Also Pearson
product–moment correlation coefficients were calculated
but results are not shown in the tables. In addition logistic
regression was used to determine the association be-
tween SDS-BMI and dichotomous classification of ele-
vated cardiometabolic risk factors. A p-value below 0.05
was considered statistically significant.Results
Demographic characteristics
Table 1 describes the demographic characteristics of the
80 participants. Of the participants, the mean age of the
group was 14.8 years, 66.2% were girls and 20% fell in
the age group 8 to 13 years. Approximately half of the
participants (55.0%) were native Dutch. Of the Immi-
grants, 5.0% were Western. Thirty-six percent of the
participants’ parents were classified as having a low level
of education and 40% and 17.5% as having a medium or
high level of education, respectively. Over 60% of the
participants lived in a family situation with a SES
below average. About half of the participants lived in
two parents family, 41.3% of the participants lived in
a single parent family. No statistically significant differ-
ences were found in demographic characteristics between
the children and adolescent groups, except for mean age.
Acanthosis nigricans was the most common comorbidity
among the participants (60%). Blount’s disease was only
present in adolescents. The percentage of participants
having gallstones differed significantly between children
and adolescents, although in absolute numbers there were
only 2 cases among children and 1 case among adoles-
cents. Almost all boys had pseudogynecomastia, among
children even 100%. Hirsutism was seen in approximately
9% of the girls. According to self reported data by the
parents of the participants, the weight of the participants
started to increase disproportionally when they were
about 5 years old and at the age of 9 the weight started to
become a real problem.
Quality of life
The mean EQ-5D utility score of the participants was 0.79
on a scale of 0.0 to 1.0 and their mean EQ VAS was 69.1
on a scale of 0 to 100. Children scored slightly lower than
adolescents (0.72 vs. 0.80) on the EQ-5D. Participants with
a SDS-BMI >= median had lower utility scores than
participants with a SDS-BMI < median (0.77 vs. 0.80), al-
though this was not significantly different. 20 children and
adolescents (25%) reported having no problems at all on
any of the five dimensions. Of the participants reporting
any problems (75%), the most reported problem was pain;
57.3% reported having (some or extreme) problems with
pain. This was followed by anxiety/depression (36.3%),
usual activity (26.3%), mobility (25.1%) and finally self care
(3.8%). No differences were found between the adolescents
and children. However, participants with a SDS-BMI >=
median had slightly more problems with mobility (35% vs.
15.4%) and pain (66.7% vs. 48.7%) than participants with a
SDS-BMI < median, although for mobility this was not
statistically significant (Figure 1). Of the participants
reporting any problems (some or extreme) on any of the
five dimensions, the majority experienced some problems.
Extreme problems were most often reported on the
Table 1 Demographic characteristics, quality of life and comorbidity of the children and adolescents participating in
HELIOS, for all participants together and stratified according to age group
Total (n = 80) Children (n = 16) Adolescents (n = 64)
N 80 16 64
Age (y) 14.8 (2.3) 11.3 (1.2)* 15.7 (1.6)*
Male/Female (%) 33.8/66.2 50/50 29.7/70.3
Ethnicities (%)
Native Dutch 55.0 68.8 51.6
Immigrants 45.0 31.2 45.5
o Western (% of total) 5.0 0.0 6.3
o Non-Western (% of total)
▪ Moroccan 5.0 6.3 4.7
▪ Dutch Antilles/Aruba 5.0 0.0 6.3
▪ Surinam 5.0 0.0 6.3
▪ Turkish 16.3 18.8 15.6
▪ Other Non-Western 6.3 6.3 6.3
Level of education of the parents (%)
Low 36.3 62.5† 29.7†
Medium 40.0 25.0† 43.8†
High 17.5 6.2† 20.3†
SES (%)
Below average 62.5 73.3 63.9
Above average 32.5 26.7 36.1
Household situation (%)
Married/living together 55.0 56.2 54.7
Divorced 33.8 37.5 32.8
One parent family(mother) 7.5 0.0 9.4
Other situation 3.8 6.2 3.1
Quality of life
EQ-5D utility score 0.79 (0.22) 0.72 (0.27) 0.80 (0.20)
EQ VAS 69.1 (21.2) 76.1 (21.3) 67.4 (21.0)
Comorbidity (%)
Acanthosis nigricans 60.0 56.2 60.9
Blount’s disease 3.8 0.0 4.7
Gallstones 3.8 12.5* 1.6*
Hirsutism (only girls) 9.4 12.5 9.1
Pseudogynecomastia (only boys) 92.6 100.0 89.5
Data are mean (SD).
Percentages are actual percentages, not valid percentages.
SD – standard deviation; SES – Socio-economic status.
A participant falls in the “Children” group if aged 8 to 13 years and falls in the “Adolescents” group if aged 13 to 19 years.
If both parents were born in the Netherlands, a participant was categorized as Native Dutch; if one of the parents was born abroad, a participant was categorized
as Immigrant. Immigrant is further divided into Western of Non-Western, of which Non-Western if further subdivided into Morocco, former Dutch Antilles and
Aruba, Surinam, Turkey and Other Non-Western.
SES below average corresponds to a status score of 0 or higher, SES above average corresponds to a status score below 0.
* P value <0.05.
† P value <0.10.
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Figure 1 Frequency of reported problems within the dimensions of the EQ-5D descriptive system stratified according to the median of
SDS-BMI. The EQ-5D descriptive system consists of five dimensions (mobility, self care, usual activities, pain/discomfort, and anxiety/depression).
SDS-BMI – standard deviation of body mass index. Median is 3.49. * P value <0.05.
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more problems with activity whereas girls tented to
have more problems with anxiety/depression, although
these differences were not statistically significant. As
for the EQ-VAS, children had a higher EQ VAS than ado-
lescents (76.1 vs. 67.4). Also participants with a SDS-
BMI < median scored higher on the EQ VAS than
participants with a SDS-BMI >= median (73.7 vs. 64.7).
These differences were not statistically significant.
Anthropometric measurements
Of the 80 participants, the mean SDS-BMI was 3.4 and the
mean fat mass percentage was 52% (Table 2). The SDS-
BMI, SDS-waist circumference, fat mass percentage, sys-
tolic blood pressure, fasting plasma insulin, fasting plasma
glucose, triglycerides and HOMA-IR were significantly
higher in participants with a SDS-BMI >= median than in
participants with a SDS-BMI < median. Also the distribu-
tion of sexes differed significantly between the SDS-BMI
groups, with more girls in the lower SDS-BMI group. There
was a statistically significant difference in SDS-BMI and
SDS-waist circumference between boys and girls; 3.7 vs. 3.3
and 3.8 vs. 3.5. With regard to age, adolescents had a statis-
tically significant higher systolic blood pressure and HS-
CRP than children (data not shown). SDS-BMI was
significantly correlated with SDS-waist circumference,
fat mass percentage, systolic blood pressure, fasting
plasma insulin, triglycerides and HOMA-IR (correlation
coefficients respectively 0.80, 0.32, 0.37, 0.49, 0.37 and
0.48). We also looked at correlations between EQ-5D util-
ity scores and anthropometric and laboratory measure-
ments, but no significant correlations were found. No
relevant differences in anthropometric measurements
were found between participants with an EQ-5D utility
score < median and participants with a score >= median.Cardiometabolic risk factors
Table 3 shows that 80% of all participants had at least 1
cardiometabolic risk factor in addition to being obese.
This was 74.4% in the lower SDS-BMI group and 85.4%
in the higher SDS-BMI group. The most common
cardiometabolic risk factors were low HDL-cholesterol
(65.0%), hypertension (31.2%) and high triglycerides
(11.2%). These risk factors were more present among
participants with a SDS-BMI above the median than
among participants with a SDS-BMI under the median,
although these differences were not significant. Further-
more, children and adolescents with a higher SDS-BMI
were 5.5 times more likely to have hypertension (OR
5.51, 95% CI 0.55, 22.18) and more than five times more
likely to have a high insulin resistance (OR 5.35, 95% CI
1.39, 20.63). In the group with a SDS-BMI >= median
fewer participants had no cardiometabolic risk factor in
addition to their obesity than in the group with a SDS-
BMI < median. Of the participants that had any car-
diometabolic risk factor in addition to obesity, more
children and adolescents in the highest SDS-BMI group
had 2 or more cardiometabolic risk factor in addition to
their obesity, whereas more children and adolescents in
the lower SDS-BMI group had only 1 cardiometabolic
risk factor in addition to their obesity. Additional ana-
lyses in which results were stratified by SDS-BMI < 3.0
(N = 9) or SDS-BMI >= 3.0 (N = 71) taken the inclusion
criteria into account, showed that 66.7% respectively
81.7% had at least 1 cardiometabolic risk factor or more
in addition to being obese (data not shown). When we
looked at the group of children and the group of adoles-
cents separately (data not shown), we saw that already
68.8% of the children between 8–13 years old had 1
cardiometabolic risk factor in addition to their obesity
and 18.8% already had 2 additional cardiometabolic risk
Table 2 Anthropometric and laboratory measurements of the children and adolescents participating in HELIOS, for all
participants together and stratified according to SDS-BMI group and Spearman’s rank correlations
Total
(n = 80)
SDS-BMI < median
(n = 39)
SDS-BMI >=
median (n = 41)
Spearman’s R with SDS-BMI Spearman’s R with
EQ-5D
Age (y) 14.8 (2.3) 14.4 (2.4) 15.2 (2.2) 0.19 0.05
Male/Female (%) 33.8/66.2 17.9/82.1** 48.8/51.2** NA NA
SDS-BMI 3.4 (0.4) 3.1 (0.2)** 3.7 (0.3)** - −0.03
SDS-waist circumference 3.6 (0.3) 3.4 (0.2)** 3.8 (0.3)** 0.80** −0.07
BIS
Fat mass (%) 52.3 (4.4) 50.5 (3.8)** 53.9 (4.4)** 0.32** −0.13
Systolic blood pressure (mmHg) 121.9 (12.8) 117.5 (11.1)** 126.1 (13.0)** 0.37** −0.09
Diastolic blood pressure (mmHg) 76.8 (11.1) 74.9 (9.4) 78.7 (12.4) 0.19 0.03
Puberty stage (%)1
Prepubertal 8.8 12.8 4.9 NA NA
Pubertal 48.8 53.8 43.9 NA NA
Postpubertal 42.5 33.3 51.2 NA NA
Fasting plasma insulin (pmol/L) 98.6 (65.1) 72.6 (40.4)** 122.7 (74.4)** 0.49** −0.12
Fasting plasma glucose (mmol/L) 4.7 (0.3) 4.6 (0.3)* 4.8 (0.3)* 0.19 −0.10
2-h plasma glucose (mmol/L) 5.8 (1.2) 5.8 (1.4) 5.9 (0.9) 0.14 −0.22†
Total cholesterol (mmol/L) 3.8 (0.7) 3.7 (0.8) 3.8(0.7) 0.09 −0.13
HDL-cholesterol (mmol/L) 1.0 (0.2) 1.1 (0.2) † 1.0 (0.2) † −0.22† −0.10
LDL-cholesterol (mmol/L) 2.3 (0.6) 2.2 (0.6) 2.3 (0.7) 0.00 −0.08
Triglycerides (mmol/L) 1.0 (0.6) 0.8 (0.4)** 1.2 (0.6)** 0.37** −0.18
HS-CRP (mg/l) 5.0 (4.6) 4.4 (4.6) 5.5 (4.6) 0.22 0.07
HbA1C (DCCT %) 5.5 (0.3) 5.5(0.3) 5.5 (0.2) 0.05 0.07
HOMA-IR 3.0 (2.1) 2.2 (1.3)** 3.8 (2.4)** 0.48** −0.15
Data are mean (SD).
SD – standard deviation; SDS-BMI – standard deviation of body mass index; SDS-waist circumference – standard deviation of waist circumference; BIS – Bio-
electrical impedance spectroscopy; HDL – high-density lipoprotein; LDL – low-density lipoprotein; HS-CRP - high sensitive C-reactive protein; HbA1C – hemoglobin
type A1C; HOMA-IR – homeostasis model assessment for insulin resistance; EQ-5D – EQ-5D descriptive system; R – correlation.
Median is 3.46.
† P value = 0.05.
* P value <0.05.
** P value < 0.01.
1 Three stages based on Tanner stages: ‘prepubertal’ equals G/M1&P1; ‘postpubertal’ equals G/M5&P5; ‘pubertal’ equals all other Tanner stages.
NA Not applicable.
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cardiometabolic risk factors in addition to obesity, for ado-
lescents this was even lower with 17.2% No differences
were found for the different cardiometabolic risk factors
between the group with a utility score < the median and
the group with a utility score >= the median (data not
shown). There was also no difference in prevalence of the
number of risk factors between these groups. Participants
with a higher utility score were not more likely to have
any of the cardiometabolic risk factors included in Table 3
(data not shown). If we combine the cardiometabolic risk
factors in our study according to the new IDF definition
of MetS, the prevalence of MetS was 27.5% in our study
population. When we took the degree of obesity into ac-
count, 23.1% in the lower SDS-BMI group had MetS,
whereas 31.7% in the higher SDS-BMI group had MetS.Discussion
This study shows that 80% of the severely obese children
and adolescents eligible for intensive inpatient treatment
programs for severely obese had at least 1 cardiometabolic
risk factor (in addition to obesity) indicating that they are
at increased risk for severe health complications. Within
this group, higher SDS-BMI was associated with a worse
profile of several cardiometabolic risk factors. The mean
EQ VAS of the participants was 69.1 on a scale of 0 to
100. Unfortunately, there are hardly studies that describe
characteristics of this specific group of severely obese chil-
dren and adolescents. Therefore there is little insight into
the health risks of this group and the urgency to quickly
detect this group and offer suitable treatment programs.
Most studies included only obese participants and not
severely obese or also obese participants, or had fewer
Table 3 The prevalence of cardiometabolic risk factors (CRF) of the children and adolescents participating in HELIOS,
for all participants together and stratified according to SDS-BMI group
Total (n = 80) SDS-BMI < median (n = 39) SDS-BMI >= median (n = 41) OR (95% CI)
High triglycerides 9 (11.2) 3 (7.7) 6 (14.6) 2.47 (0.42, 14.64)
Low HDL-cholesterol 52 (65.0) 24 (61.5) 28 (68.3) 1.49 (0.55, 4.94)
Hypertension 25 (31.2) 9 (23.1) 16 (39.0) 5.51 (1.37, 22.18)*
Impaired fasting glucose 1 (1.2) 1 (2.6) 0 (0) -
Impaired glucose tolerance 5 (6.2) 4 (10.3) 1 (2.4) -
DMII 0 (0.0) - - -
High HOMA-IR 30 (37.5) 9 (23.1)** 21 (51.2)** 5.35 (1.39, 20.63)*
1 CRF (only obesity) 16 (20.0) 10 (25.6) 6 (14.6) NA
2 CRF (1 in addition to obesity) 39 (48.8) 18 (46.2) 21 (51.2) NA
>= 3 CRFs (>= 2 in addition to obesity) 25 (31.3) 11 (28.2) 14 (34.1) NA
Data are n (% of total) and OR with 95% CI.
OR – Odds Ratio; SDS-BMI – standard deviation of body mass index; CI – confidence interval; HDL – High Density Lipoprotein; HOMA-IR – homeostasis model
assessment for insulin resistance: DMII – Diabetes Mellitus type II.
Reference cut off points cardiometabolic risk from ‘The metabolic syndrome in children and adolescents – an IDF consensus report’ by Zimmet et al. [27].
Reference cut off points HOMA-IR from ‘Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods’ by
Kurtoğlu et al. [25], ‘Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for
assessing insulin resistance among obese children and adolescents’ by Keskin et al. for postpubertal stage [26].
CRFs are based on the IDF criteria including obesity, high triglycerides, low HDL-cholesterol, hypertension, impaired fasting glucose, impaired glucose tolerance
and DMII. Since all participants fulfilled the IDF criterion for obesity, none of the participants had zero CRF. Participants with 1 CRF only had obesity and none of
the other CRFs. Participants with 2 CRFs had 1 CRF in addition to obesity. Participants with 3 or more CRFs had 2 or more CRFS in addition to obesity. HOMA-IR is
not taken into account in the number of CRFs.
Median is 3.49.
- Insufficient sample size.
* P value <0.05.
** P value < 0.01.
NA Not applicable.
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and clinical characteristics of the study population are
only described after treatment. In our study, we see a ten-
dency; the higher the SDS-BMI and higher the degree of
obesity, the higher the prevalence of MetS. This is also
seen in a study by Weiss et al. [29], although the z-scores
of BMI in our study population are much higher. Weiss
et al. found that 38.7% of the participants with moderate
obesity (defined as 2.0 < SDS-BMI = < 2.5) and 49.7% with
severe obesity (SDS-BMI > 2.5) were diagnosed with
MetS. Thus, the prevalence of cardiometabolic risk factors
seems to increase with worsening obesity, even in the
upper regions. The most common cardiometabolic risk
factor seen in our study population is low HDL-
cholesterol (65.0%), followed by hypertension (31.2%) and
high triglycerides (11.2%). In the Lafortuna study, hyper-
tension was the most prevalent component of MetS
(66.1% for Germans vs. 44.7% for Italians), followed by
low HDL-cholesterol (39.5% vs. 37.4% respectively). Ado-
lescents had higher prevalences of cardiometabolic risk
factors than children in our study population. This was
also found by Lafortuna et al., in which the prevalences of
almost all components of MetS increased with age groups.
There are only a few studies that looked at the relation-
ship between childhood obesity and quality of life, and al-
most none that studied this association in severely obese
children and adolescents. In our study we found that theaverage score on a scale of 0 to 100 was 69.1. Since we
only included severely obese children and adolescents in
our study population, we cannot directly compare our re-
sults to a similar group of normal weight children. How-
ever, we did compare our results with existing literature
describing quality of life in obese children and adolescents.
The EQ-VAS score of 69 found in this study suggests that
participants experience important limitations in their
quality of life. This was also found by Schwimmer et al.
who used the PedsQL to assess quality of life in obese and
normal weight children [14]. They found that obese chil-
dren had a significantly lower mean health-related quality
of life score compared to healthy children and adolescents
(mean score 67.0 vs. 83.0) and that they were 5.5 times
more likely to have impaired health-related quality of life
than a healthy child or adolescent, which is similar to a
child or adolescent with cancer. Williams et al. also used
the PedsQL 4.0 and compared schoolchildren with normal
weight, overweight and obesity to each other [30]. They
found total mean scores of respectively 80.5, 79.3 and
74.0. The degree of obesity was taken into account by
Varni et al. [31]. Severely obese children self reported sig-
nificantly lower overall health-related quality of life, phys-
ical health, psychosocial health, and school functioning in
comparison to obese children. The results of a recent
study by Philips et al. also suggest the ‘extremely obese’
are significantly more depressed, more socially anxious
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[32]. We report similar findings in our study (higher BMI,
poorer quality of life), although our results were not statis-
tically significant. We did not find a relationship between
quality of life and the presence of cardiovascular risk fac-
tors, like Nadeau et al. did [33]. In their study, a higher
body mass index and greater number of comorbidities
were associated with diminished health-related quality of
life. The difference may be explained by the fact that
Nadeau et al. used a disease specific questionnaire, which
is probably more sensitive to detect limitations related to
obesity than the general quality of life questionnaire we
used in our study. All children that participated in this
study were referred to obesity center Heideheuvel by their
pediatricians. Since not every severely obese child or ado-
lescent in the Netherlands will have been under the care
of a pediatrician and therefore was not able to participate
in the study, participants of HELIOS were probably a se-
lection from the total group of severely obese children
and adolescents in the Netherlands. It is unknown if the
children and adolescents not being referred by pediatri-
cians differ in characteristics from the children and ado-
lescents that were being referred. It is possible that the
children and adolescents that were to seek help from a
pediatrician were also the ones already suffering from
cardiometabolic risk factors. Also, the inclusion of partici-
pants with a SDS-BMI between 2.3 and 3.0 with co-
morbidity can lead to a preselected sample and therefore
has a higher prevalence of these factors than a general
population of obese children. In practice, 7 participants
had a SDS-BMI between 2.3-3.0 (2.9, 2.8, 2.9, 2.5, 2.8, 2.6,
and 2.5). Of these participants, 0 had impaired fasting glu-
cose, 0 had impaired glucose tolerance, 0 had diabetes
mellitus type II, 4 had insulin resistance, 1 had hyperten-
sion, and 6 had low HDL-cholesterol. Indeed, some of
them already had cardiometabolic risk factors, but in
general we saw a higher prevalence of these risk fac-
tors among those with a higher SDS-BMI. A strong point
of this study is the large number of participants that
came from all parts of the Netherlands. Many studies
with a severely obese children and/or adolescents study
population had fewer participants and participants for a
limited area that did not present the country. This article
was written since the prevalence of severe obesity is
rising in children and adolescents worldwide; a good
description of particularly this population is needed. The
results in this article clearly demonstrate that most
severely obese children and adolescents already have
several cardiometabolic risk factors present and are at
high risk for developing cardiometabolic disease in young
adulthood. These findings stress the importance and
need of the early detection of these children, of the
availability of appropriate intensive treatment programs
and of the early screening for cardiometabolic risk factors.It is even more important to prevent them from becoming
severely obese, because effects of treatment can be lower
than desired resulting from the complexity within the
group of severely obese children and adolescents to pre-
vent the development of cardiometabolic risk factors and
diabetes and impaired quality of life.
Conclusions
Cardiometabolic risk factors are already highly prevalent
in this group of severely obese children and adolescents,
80% had at least 1 cardiometabolic risk factor (in
addition to obesity). The score of 69.1 found for quality
of life in this study suggests that participants experience
important limitations in their quality of life. However,
quality of life is not associated with the prevalence of
cardiometabolic risk factors.
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